Jeonjinbio Co. Ltd (110020) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.018x

Based on the latest financial reports, Jeonjinbio Co. Ltd (110020) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩313.21 Million ≈ $212.26K USD) by net assets (₩17.72 Billion ≈ $12.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jeonjinbio Co. Ltd (110020) balance sheet quality index to measure how much of total assets are equity-financed.

Jeonjinbio Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Jeonjinbio Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Jeonjinbio Co. Ltd to evaluate the quality of earnings relative to operating cash generation.

Jeonjinbio Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jeonjinbio Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CVS Group Plc LSE:CVSG	0.145x
Kiora Pharmaceuticals Inc NASDAQ:KPRX	-0.227x
Progressive Impact Corporation Bhd KLSE:7201	0.520x
Clemondo Group AB (publ) ST:CLEM	0.040x
Pacific Horizon Investment Trust LSE:PHI	0.001x
Big Rock Brewery Inc. TO:BR	-0.021x
SL Private Equity LSE:SLPE	-0.001x
EV RESOURCES LTD. F:R1EA	N/A

Annual Cash Flow Conversion Efficiency for Jeonjinbio Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of Jeonjinbio Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Jeonjinbio Co. Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩17.66 Billion ≈ $11.97 Million	₩3.01 Billion ≈ $2.04 Million	0.170x	+452.06%
2023-12-31	₩6.22 Billion ≈ $4.21 Million	₩-300.60 Million ≈ $-203.71K	-0.048x	+87.61%
2022-12-31	₩9.51 Billion ≈ $6.44 Million	₩-3.71 Billion ≈ $-2.51 Million	-0.390x	-76.65%
2021-12-31	₩10.80 Billion ≈ $7.32 Million	₩-2.38 Billion ≈ $-1.62 Million	-0.221x	-7.88%
2020-12-31	₩11.28 Billion ≈ $7.65 Million	₩-2.31 Billion ≈ $-1.57 Million	-0.205x	+54.32%
2019-12-31	₩2.90 Billion ≈ $1.96 Million	₩-1.30 Billion ≈ $-880.34K	-0.448x	+18.90%
2018-12-31	₩3.91 Billion ≈ $2.65 Million	₩-2.16 Billion ≈ $-1.46 Million	-0.553x	+69.24%
2017-12-31	₩229.96 Million ≈ $155.84K	₩-413.19 Million ≈ $-280.01K	-1.797x	-2154.30%
2016-12-31	₩2.28 Billion ≈ $1.55 Million	₩-181.90 Million ≈ $-123.27K	-0.080x	+94.83%
2015-12-31	₩1.27 Billion ≈ $858.87K	₩-1.95 Billion ≈ $-1.32 Million	-1.541x	--

About Jeonjinbio Co. Ltd

KQ:110020 Korea Specialty Chemicals

Market Cap

$10.68 Million

₩15.75 Billion KRW

Market Cap Rank

#26860 Global

#2021 in Korea

Share Price

₩1739.00

Change (1 day)

+0.69%

52-Week Range

₩1641.00 - ₩3895.00

All Time High

₩16700.00